Gregory Lazarian

8PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)AllergyHaematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 06, 2025
TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma.

Grégory Lazarian, Lotfi Chemali, Merieme Bensalah

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|May 10, 2024
Clinical and biological characterization of involvement of nasal-associated lymphoid tissues in chronic lymphocytic leukemia.

Thimali Ranaweera Arachchige, Catherine Mendiburu, Antoine Martin

|Jan 27, 2022
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia.

Grégory Lazarian, Floriane Theves, Myriam Hormi

|Nov 25, 2021
Post-SARS-CoV-2 vaccination acute hemolysis in an older man: don't forget to look at the blood smear.

Boris Duchemann, Gregory Lazarian

|Jun 21, 2021
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).

Grégory Lazarian, Michaël Munger, Anne Quinquenel

Pageof 2

Frequent Collaborators

3 joint publications

Virginie Eclache

2 joint publications

Anne Quinquenel

2 joint publications

Audrey Bidet

2 joint publications

Thierry Soussi